Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
A detailed analysis of the results of a multi-centre clinical trial shows that, while the relapse rate following recovery from an operationally defined depressive illness was smaller among patients subsequently treated with either amitryptiline or lithium than with a placebo, there was no clinically significant difference between the prophylactic efficacy of the 2 antidepressants. An account is given of the relative adverse effects of the treatments, and the implications of the findings are discussed.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on